© 2020 MJH Life Sciences and Patient Care Online. All rights reserved.
July 09, 2020
Diabetes is a primary risk factor for atherosclerotic cardiovascular disease. Find out how well you know the guideline recommendations for reducing that risk with the first of 4 quizzes.
July 02, 2020
SGLT2 inhibitors and GLP-1 receptor agonists are changing the type 2 diabetes treatment paradigm. We summarize the most recent data here and offer guidance on patient benefits.
November 17, 2017
Migraine-especially with aura-is a CV risk factor, which makes treatment with ergots or triptans potentially problematic. The best approach?